0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
The Minister of Food and Drug Safety Kim Gang-rip said in a briefing on the 27th, "We expect that Paxlovid will help diversify the types of treatments along with injection-type treatments currently used in hospitals, and will prevent patients from being severe." Currently, 'Regkirona,' developed by Celltrion, is used for the injection-type treatment.
Share this article
If you liked this article share it with your friends.they will thank you later